W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies
X

Transparency Council

Transparency Council meeting 20/2022 on 23.05.2022

more...

Opinion of the Transparency Council – sunitinib

more...

Opinion of the Transparency Council – capecitabine

more...

Opinion of the Transparency Council – posaconazolum

more...

Opinion of the Transparency Council – lacosamide

more...

Opinion of the Transparency Council – carbamazepine

more...

Opinion of the Transparency Council – Health Policy Program of the Municipality of Kalisz Pomorski on medical rehabilitation

more...

Position of the Transparency Board – Granulox (haemoglobin spray)

more...

Position of the Transparency Council – Tysabri (natalizumabum), subcutaneous form

more...

Position of the Transparency Board – Tysabri (natalizumabum), intravenous form

more...

Opinion of the Transparency Council – TLI

more...

Opinion of the Transparency Council – peginterferonum alfa-2a

more...

Transparency Council meeting 19/2022 on 16/05/2022

more...

Transparency Council Meeting 17/2022 on 02/05/2022

more...

Opinion of the Transparency Council – Cervical cancer prevention

more...

Position of the Transparency Council – Wakix (pitolisantum)

more...

Opinion of the Transparency Council on the health policy programme of the city of Darłowo on prophylaxis of prostate cancer

more...

Opinion of the Transparency Council on the health policy programme of the Jawor Municipality concerning prevention of pneumococcal infections

more...

Opinion of the Transparency Council on the health policy programme of the Głogów Municipality concerning treatment of infertility

more...

Transparency Council meeting 16/2022 on 25.04.2022

more...

Opinion of the Transparency Council – active substance prednisolonum

more...

Opinion of the Transparency Council – health policy program on prevention of depressive disorders (Mazowieckie voivodeship)

more...

Opinion of the Transparency Council – changes in the drug program concerning atypical hemolytic uremic syndrome

more...

Position of the Transparency Council – Ravicti (glyceroli phenylbutyras)

more...